KURA Data Readout: a negative outcome, -7.5%

On May 26, 2026, Kura Oncology, Inc. reached its Data Readout. The result was a negative outcome, and the stock moved -7.5% in the window around the event. It had already run +21.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.